CliffBio
small molecule

POKONZA

POTASSIUM CHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyGenus Lifesciences Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand namePOKONZA
Active ingredientPOTASSIUM CHLORIDE
Strength15MEQ
Dosage formFOR SOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalNovember 2025
Marketing statusRX

More from Genus Lifesciences Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

POKONZA patent cliff — loss of exclusivity — | CliffBio